The pinnacle of biomedical research is the ongoing development of cancer medicines. The strong therapeutic potential exists when the immune system is targeted and biological processes are used to enhance the body’s response to cancer. Mesenchymal stem cells (MSCs) are a particular kind of cell that may develop into several types of tissue and play a part in tissue regeneration and repair.
Mesenchymal stem cells also have immunomodulatory properties, which are attracting a lot of interest as a prospective strategy for the development of cell and gene treatments. For instance, based on what is necessary for tissue repair, MSCs can control the inflammatory and immunological response in the body by triggering specific immune cells.